In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group.
Sign Up to like & getrecommendations! Published in 2018 at "Anaerobe"
DOI: 10.1016/j.anaerobe.2018.08.002
Abstract: The in vitro activities of lascufloxacin were evaluated by comparison with seven reference compounds using 412 clinical isolates of anaerobes and Streptococcus anginosus group. Lascufloxacin showed potent and broad antibacterial activities greater than those of existing… read more here.
Keywords: anaerobes streptococcus; streptococcus anginosus; isolates anaerobes; anginosus group ... See more keywords